178 related articles for article (PubMed ID: 9708910)
1. Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26/dipeptidyl peptidase IV.
Ohtsuki T; Hosono O; Kobayashi H; Munakata Y; Souta A; Shioda T; Morimoto C
FEBS Lett; 1998 Jul; 431(2):236-40. PubMed ID: 9708910
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
3. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
[TBL] [Abstract][Full Text] [Related]
4. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
Christopherson KW; Hangoc G; Broxmeyer HE
J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
6. Good or evil: CD26 and HIV infection.
Ohtsuki T; Tsuda H; Morimoto C
J Dermatol Sci; 2000 Apr; 22(3):152-60. PubMed ID: 10698152
[TBL] [Abstract][Full Text] [Related]
7. Comodulation of CXCR4 and CD26 in human lymphocytes.
Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
[TBL] [Abstract][Full Text] [Related]
8. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
9. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E
Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827
[TBL] [Abstract][Full Text] [Related]
10. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
[TBL] [Abstract][Full Text] [Related]
11. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
Christopherson KW; Cooper S; Broxmeyer HE
Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
Proost P; De Meester I; Schols D; Struyf S; Lambeir AM; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
J Biol Chem; 1998 Mar; 273(13):7222-7. PubMed ID: 9516414
[TBL] [Abstract][Full Text] [Related]
13. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
15. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
Narducci MG; Scala E; Bresin A; Caprini E; Picchio MC; Remotti D; Ragone G; Nasorri F; Frontani M; Arcelli D; Volinia S; Lombardo GA; Baliva G; Napolitano M; Russo G
Blood; 2006 Feb; 107(3):1108-15. PubMed ID: 16204308
[TBL] [Abstract][Full Text] [Related]
16. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
Lambeir AM; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
J Biol Chem; 2001 Aug; 276(32):29839-45. PubMed ID: 11390394
[TBL] [Abstract][Full Text] [Related]
17. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
18. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
Li H; Wang YS
Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
[TBL] [Abstract][Full Text] [Related]
19. Stromal-cell-derived factor-1/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45.
Okabe S; Tauchi T; Ohyashiki K; Broxmeyer HE
Blood Cells Mol Dis; 2006; 36(2):308-14. PubMed ID: 16503409
[TBL] [Abstract][Full Text] [Related]
20. Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo.
Villalba S; Salvucci O; Aoki Y; De La Luz Sierra M; Gupta G; Davis D; Wyvill K; Little R; Yarchoan R; Tosato G
J Leukoc Biol; 2003 Nov; 74(5):880-8. PubMed ID: 12960279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
